Rhinorus, drops 0.05%, 10ml

Product description

Minimum order quantity-2 pieces

Composition

>

1 ml contains:

Active ingredient:

xylometazoline hydrochloride 0.5 mg;

Auxiliary substances:

benzalkonium chloride,

sodium chloride,

disodium edetate,

sodium dihydrogen phosphate dihydrate,

sodium hydrophosphate dodecahydrate,

eucalyptus oil,

d/i water.

Pharmacological action

Vasoconstrictor drug for topical use in ENT practice.

Xylometazoline (imidazoline derivative) is an alpha-adrenomimetic, causes narrowing of the blood vessels of the nasal mucosa, eliminating its edema and hyperemia, restores patency of the nasal passages, facilitates nasal breathing and improves the discharge of nasal secretions in rhinitis (runny nose) of various origins.

The effect of the drug occurs a few minutes after its application and lasts up to 10 hours.

Indications

• acute rhinitis (including against the background of acute respiratory diseases and allergic rhinitis);
• sinusitis;
• eustachiitis;
• otitis media (as part of combination therapy to reduce swelling of the nasopharyngeal mucosa);
• to facilitate rhinoscopy;
• preparation of patients for diagnostic manipulations in the nasal passages.

Use during pregnancy and lactation

During pregnancy and lactation, the drug should be used only after careful assessment of the ratio of benefit to the mother and risk to the fetus and child, with caution, it is not allowed to exceed the recommended doses.

Contraindications

• hypertension;
• tachycardia;
• severe atherosclerosis;
• glaucoma;
• atrophic rhinitis;
• hyperthyroidism;
• surgical interventions on the meninges (history);
• pregnancy (for nasal drops);
• children’s age up to 2 years old;
• children up to age 6 years (for nasal drops 0.1% and nasal spray 0.1%);
• hypersensitivity to product components (including the oil of eucalyptus).

Do not use in therapy with MAO inhibitors and tricyclic antidepressants, as well as with other drugs that increase blood pressure.

With caution, the drug should be prescribed for diabetes mellitus, coronary heart disease, angina pectoris of functional class III-IV, prostatic hyperplasia, during lactation.

Side effects

Local reactions:  with frequent and/or prolonged use – irritation and/or dryness of the nasopharyngeal mucosa, burning, paresthesia, sneezing, hypersecretion; rarely – swelling of the nasal mucosa.

Systemic reactions:  vomiting, headache, palpitation, increased blood pressure, insomnia, visual impairment, depression (with prolonged use of high doses).

Interaction

It is possible to increase the systemic effect with simultaneous use of monoamine oxidase (MAO) inhibitors and tricyclic antidepressants.

How to take, course of use and dosage

Adults and children over 6 years of age are instilled 2-3 drops of 0.1% solution in each nasal passage 3-4 times a day.

Children from 2 to 6 years old are instilled with a 0.05% solution of 1-2 drops in each nasal passage-1-2 times a day. Do not use more than 3 times a day.

Duration of treatment-no more than 3-5 days (without interruption).

Before using the drug, unscrew the cap of the bottle and instill it in the nose by lightly pressing the bottom of the bottle.

Overdose

Symptoms:  increased side effects.

Treatment:  symptomatic under the supervision of a doctor.

Special instructions

Do not exceed the recommended dose and use for a long time. Before use, it is necessary to clean the nasal passages. Do not apply for more than 7 days.

Form of production

Nasal drops.

Storage conditions

In a dry place, protected from light, at a temperature not exceeding 25 °C.

Shelf

life is 2 years.

Active ingredient

Xylometazoline

Dosage form

nasal drops

Description

Children’s forms